{
    "table_name": "Purity_Ploidy_All_Samples_filtered",
    "table_fullname": "pancancer-atlas.Filtered.Purity_Ploidy_All_Samples_filtered",
    "column_names": [
        "AliquotBarcode",
        "ParticipantBarcode",
        "SampleBarcode",
        "CallStatus",
        "Purity",
        "Ploidy",
        "Genome_doublings",
        "Coverage_for_80_power",
        "Cancer_DNA_fraction",
        "Subclonal_genome_fraction",
        "Solution",
        "Study",
        "SampleTypeLetterCode",
        "SampleType"
    ],
    "column_types": [
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "FLOAT64",
        "FLOAT64",
        "FLOAT64",
        "FLOAT64",
        "FLOAT64",
        "FLOAT64",
        "STRING",
        "STRING",
        "STRING",
        "STRING"
    ],
    "nested_column_names": [
        "AliquotBarcode",
        "ParticipantBarcode",
        "SampleBarcode",
        "CallStatus",
        "Purity",
        "Ploidy",
        "Genome_doublings",
        "Coverage_for_80_power",
        "Cancer_DNA_fraction",
        "Subclonal_genome_fraction",
        "Solution",
        "Study",
        "SampleTypeLetterCode",
        "SampleType"
    ],
    "nested_column_types": [
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "FLOAT64",
        "FLOAT64",
        "FLOAT64",
        "FLOAT64",
        "FLOAT64",
        "FLOAT64",
        "STRING",
        "STRING",
        "STRING",
        "STRING"
    ],
    "description": [
        "TCGA aliquot barcode, eg TCGA-12-1089-01A-01D-0517-28",
        "TCGA barcode identifier for the study participant, eg TCGA-02-0001",
        "Barcode of the biospecimen sample, eg TCGA-13-1489-02A",
        "Either 'called' or NULL indicating if data data were analyzed or not, respectively",
        "Purity estimates; values betwen 0 and 1 representing the fraction of cancer cells in a solid tumor sample",
        "Value based on the DNA content of the tumor cell population compared to normal diploid",
        "Number of whole genome doublings",
        " Average coverage necessary to obtain 80% power in 80% fraction of the genome",
        "Cancer DNA fractions; more information available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383288/",
        "Subclonal genome fractions; more information available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383288/",
        "New' or 'old' calculations/solutions",
        "TCGA study abbreviation, eg LAML. Full list available at https://gdc.cancer.gov/resources-tcga-users/tcga-code-tables/tcga-study-abbreviations",
        "Letter code of the sample type using the TCGA standards, eg TPN, EBV. Full list available at https://gdc.cancer.gov/resources-tcga-users/tcga-code-tables/sample-type-codes",
        "There are 10 sample types: Blood Derived Normal, Primary solid Tumor, Solid Tissue Normal, Recurrent Solid Tumor, Metastatic, Additional - New Primary, Primary Blood Derived Cancer - Peripheral Blood, Buccal Cell Normal, Additioanal Metastatic, Bone Marrrow Normal"
    ],
    "sample_rows": [
        {
            "AliquotBarcode": "TCGA-78-7160-01A-11D-2035-01",
            "ParticipantBarcode": "TCGA-78-7160",
            "SampleBarcode": "TCGA-78-7160-01A",
            "CallStatus": "called",
            "Purity": 0.29,
            "Ploidy": 1.62,
            "Genome_doublings": 0.0,
            "Coverage_for_80_power": 34.0,
            "Cancer_DNA_fraction": 0.25,
            "Subclonal_genome_fraction": 0.41,
            "Solution": "new",
            "Study": "LUAD",
            "SampleTypeLetterCode": "TP",
            "SampleType": "Primary solid Tumor"
        },
        {
            "AliquotBarcode": "TCGA-77-A5GB-01B-11D-A27J-01",
            "ParticipantBarcode": "TCGA-77-A5GB",
            "SampleBarcode": "TCGA-77-A5GB-01B",
            "CallStatus": "called",
            "Purity": 0.28,
            "Ploidy": 1.72,
            "Genome_doublings": 0.0,
            "Coverage_for_80_power": 36.0,
            "Cancer_DNA_fraction": 0.25,
            "Subclonal_genome_fraction": 0.26,
            "Solution": "new",
            "Study": "LUSC",
            "SampleTypeLetterCode": "TP",
            "SampleType": "Primary solid Tumor"
        },
        {
            "AliquotBarcode": "TCGA-91-6830-01A-11D-1943-01",
            "ParticipantBarcode": "TCGA-91-6830",
            "SampleBarcode": "TCGA-91-6830-01A",
            "CallStatus": "called",
            "Purity": 0.28,
            "Ploidy": 1.72,
            "Genome_doublings": 0.0,
            "Coverage_for_80_power": 36.0,
            "Cancer_DNA_fraction": 0.25,
            "Subclonal_genome_fraction": 0.16,
            "Solution": "new",
            "Study": "LUAD",
            "SampleTypeLetterCode": "TP",
            "SampleType": "Primary solid Tumor"
        },
        {
            "AliquotBarcode": "TCGA-EJ-A65B-01A-12D-A30D-01",
            "ParticipantBarcode": "TCGA-EJ-A65B",
            "SampleBarcode": "TCGA-EJ-A65B-01A",
            "CallStatus": "called",
            "Purity": 0.26,
            "Ploidy": 1.89,
            "Genome_doublings": 0.0,
            "Coverage_for_80_power": 40.0,
            "Cancer_DNA_fraction": 0.25,
            "Subclonal_genome_fraction": 0.04,
            "Solution": "new",
            "Study": "PRAD",
            "SampleTypeLetterCode": "TP",
            "SampleType": "Primary solid Tumor"
        },
        {
            "AliquotBarcode": "TCGA-C8-A8HR-01A-11D-A36I-01",
            "ParticipantBarcode": "TCGA-C8-A8HR",
            "SampleBarcode": "TCGA-C8-A8HR-01A",
            "CallStatus": "called",
            "Purity": 0.26,
            "Ploidy": 1.85,
            "Genome_doublings": 0.0,
            "Coverage_for_80_power": 40.0,
            "Cancer_DNA_fraction": 0.25,
            "Subclonal_genome_fraction": 0.21,
            "Solution": "new",
            "Study": "BRCA",
            "SampleTypeLetterCode": "TP",
            "SampleType": "Primary solid Tumor"
        }
    ]
}